# ALINA (NCT03456076)

> A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03456076
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Hoffmann-La Roche
- Conditions: Carcinoma, Non-Small-Cell Lung
- Interventions: Alectnib; Cisplatin; Vinorelbine; Gemcitabine; Pemetrexed; Carboplatin
- Enrollment: 257
- Primary outcome: Disease-free Survival (DFS), as Assessed by the Investigator

## Indexed commentary on ALINA so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 198
- YouTube: 99
- Podcasts: 63
- X videos: 2
- Bluesky threads: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=alina-nct03456076

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03456076", "email": "<work email>"}; the inbox owner confirms by the emailed link.